Medication development for cocaine-addicted patients is difficult, and many promising preclinical candidates have failed in clinical trials. One reason for the difficulty in translating preclinical findings to the human condition is that drug testing is typically conducted in behavioral procedures in which animals do not show addiction-like traits. Recently, a DSM-IV-based animal model has been developed that allows studying the transition to an addiction-like behavior. Changes in synaptic plasticity are involved in the transition to cocaine addiction. In particular, it has been shown that metabotropic glutamate receptor 2/3 (mGluR2/3)-mediated long-term depression is suppressed in the prelimbic cortex in addict-like rats. We therefore hypothesized that cocaine-seeking in addict-like rats could be treated with an mGluR2/3 agonist. Indeed, addict-like rats that were treated systemically with the mGluR2/3 agonist LY379268 (0, 0.3, and 3 mg/kg) showed a pronounced reduction in cue-induced reinstatement of cocaine-seeking. In an attempt to dissect the role played by mGluR2 and mGluR3 in cue-induced reinstatement, we analyzed the mRNA expression patterns in several relevant brain areas but did not find any significant differences between cocaine addict-like and non-addict-like rats, suggesting that the behavioral differences observed are due to translational rather than transcriptional regulation. Another possibility to study the contributions of mGluR2 and mGluR3 in mediating addictive-like behavior is the use of knockout models. Because mGluR2 knockouts cannot be used in operant procedures due to motoric impairment, we only tested mGluR3 knockouts. These mice did not differ from controls in reinstatement, suggesting that mGluR2 receptors are critical in mediating addictive-like behavior.
INTRODUCTION
Addiction is a psychiatric disorder characterized by the loss of control over drug intake and a high vulnerability to relapse despite prolonged abstinence. Addictive behavior is diagnosed only in a small proportion of drug users who shift from controlled drug intake to compulsive use. The main neurobiological pathways and mechanisms driving drug self-administration have been previously identified (Koob and Volkow, 2010; Noori et al, 2012) ; however, the specific neuroanatomical substrates and mechanisms causing the transition to addiction are largely unknown, as animal models attempting to mimic the transition to addiction-like behavior have been developed only recently (Ahmed and Koob, 1998; Belin et al, 2009; DerocheGamonet et al, 2004; Pelloux et al, 2007;  for review, see Sanchis-Segura and Spanagel, 2006 ; for an historical perspective, see Wikler and Pescor, 1967 ; and also Wolffgramm and Heyne, 1995) .
Recent work has provided initial insight into the neurobiological mechanisms involved in the transition to an addiction-like behavior. Using a self-administration procedure in rats that has been introduced as a DSM-IVbased model of cocaine addiction (Deroche-Gamonet et al, 2004) , it was reported that during the early phase of cocaine self-administration, when addiction-like behavior had not yet developed, subjects showed a suppression of NMDA-dependent long-term depression (LTD) in the nucleus accumbens (NAc). However, after prolonged self-administration, during which addiction-like behavior developed in a subset of animals, LTD was recovered in non-addict-like, but not in addict-like rats. Thus, the pathological state of addictive-like behavior appears to be characterized by a loss of synaptic plasticity-a phenomenon termed as anaplasticity (Kasanetz et al, 2010) . Furthermore, a synaptic marker of addiction-like behavior was found in the prelimbic medial prefrontal cortex (PreL), in which metabotropic glutamate receptors 2/3 (mGluR2/3)-mediated LTD was impaired in addict-like, but not in non-addict-like subjects (Kasanetz et al, 2012) . Altogether, it has been proposed that the transition to addiction-like behavior is mediated by a lack of rescaling of synaptic potentiation occurring hierarchically in the limbic forebrain; ie, a persistent loss of NMDA-LTD in the NAc leading ultimately to a dysfunction of mGluR2/3 signaling in the prefrontal cortex (Kasanetz et al, 2010 (Kasanetz et al, , 2012 .
The release of glutamate from the PreL into the NAc core has been identified as the final common pathway driving relapse to cocaine-seeking, and an alteration in glutamate homeostasis in the limbic forebrain has been implicated in addiction (Kalivas, 2009; Kalivas and Volkow, 2005) . In addition, a history of cocaine intake causes a decrease in basal extracellular glutamate levels, leading to a hypoactivation of inhibitory presynaptic mGluR2/3 receptors. Consequently, upon exposure to drug cues or stress, the synaptic release of glutamate in the NAc core is no longer compensated for via presynaptic inhibitory mechanisms, causing a loss of control over cocaine-seeking (Kalivas, 2009 ). This suggests that mGluR2/3 activation by direct agonists or potentiators, or alternatively by re-establishing physiological levels of glutamate, may be a suitable treatment for relapse behavior. Indeed, activating the glial cystine-glutamate exchanger during extinction of cocaine-seeking with daily treatment of the cystine prodrug N-acetylcysteine induced an enduring normalization of extra-synaptic glutamate levels in the NAc core, and blocked reinstatement of cocaine-seeking through restoration of the glutamate tone on mGluR2/3 (Baker et al, 2003; Moussawi et al, 2011) . Furthermore, exogenous activation of mGluR2/3 with its agonist LY379268 has been demonstrated to block reinstatement of cocaine-seeking induced by cues (Baptista et al, 2004) , a priming dose of cocaine (Peters and Kalivas, 2006) , and stress (Martin-Fardon and Weiss, 2012) , as well as to impair the incubation of cocaine craving . Importantly, the role of mGluR2/3 agonists on cocaine-related behaviors has, to date, been studied only in non-dependent animals that had limited exposure to cocaine (12-24 days).
Here, we present data on the role of mGluR2/3 in addictlike and non-addict-like cocaine-experienced rats using the aforementioned DSM-IV-based rat model. We first report on the effect of the mGluR2/3 agonist LY379268 in cue-induced reinstatement in addict-like vs non-addict-like rats and then present quantitative gene expression data on mGluR2 and mGluR3 following withdrawal from cocaine self-administration. To further dissect the role of these two different metabotropic glutamate receptors, we present data on cocaine self-administration, drug escalation, and cue-induced reinstatement in mGluR3 knockout (mGluR3 À / À ) mice (Corti et al, 2007) . Motoric impairments preclude the use of mGluR2 knockouts for operant studies (Morishima et al, 2005) .
MATERIALS AND METHODS
All experiments were conducted at the Central Institute of Mental Health in Mannheim (Germany). Experimental procedures were in accordance with the NIH ethical guidelines for the care and use of laboratory animals, and were approved by the local animal care committee (Regierungspräsidium Karlsruhe, Germany).
Experiments in Rats
Male Sprague-Dawley rats were used in experiments 1 and 2, in which we used the DSM-IV-based rat model of cocaine addiction published by Deroche-Gamonet et al (2004) . A cocaine self-administration session was composed of three 40-min 'Drug-periods' in which cocaine was delivered contingent upon nose-pokes at 0.8 mg/kg/infusion under Fixed Ratio (FR) 5, associated with a discrete white cue light and followed by a 40-s Time-Out (TO) period separated by two 15-min 'No-Drug-periods' discriminated by distinct light contexts; a blue cue light was on during 'Drug-periods' (except during TO), while the box was entirely illuminated by the house light during the 'No-Drug-periods'. After 45 sessions, rats were tested on the following three addictionlike criteria: (A) motivation for cocaine-taking, measured in a progressive ratio session, during which the break point achieved was used to score motivation; (B) persistence of cocaine-seeking, during which the subject continued to nose-poke for cocaine despite the unavailability of the drug, scored as the number of nose-pokes in the active hole; and (C) resistance to punishment, during which the subject continued to nose-poke for cocaine despite aversive consequences (two electric foot-shocks paired with cocaine-seeking and infusion, 0.8 mA in experiment 1 and 0.2 mA in experiment 2), scored as percent of baseline active poking. A subject was considered as positive for one criterion if its score was above the 60th percentile of the population distribution. Thus, depending on the number of positive criteria met, a subject was assigned to one of the following groups: 0crit, 1crit, 2crit, and 3crit. Rats negative for all criteria (0crit) were characterized as non-addict-like, whereas rats positive for all criteria (3crit) were characterized as addict-like (details in Supplementary Information). These two groups were subsequently used for further experiments.
Addiction score. An addiction score, a dimensional index of cocaine use severity described in Supplementary Information, was also calculated for each animal.
Reinstatement of cocaine-seeking. Cue-induced reinstatement of cocaine-seeking was tested after 30 days of withdrawal in 0crit and 3crit rats, during a unique 2-h session in which cocaine was not available. This session consisted of two periods; one initial 1-h period of extinction, during which nose-pokes in either hole had no scheduled consequences, was followed by 1-h during which the 'Drug-period' discriminative light (blue cue light) was illuminated and the white cue associated with cocaine delivery during training was presented contingently to nose-pokes into the active hole.
Experiment 1: Effect of LY379268 on Cue-Induced Reinstatement in Addict-like and Non-Addict-like Rats. The effect of systemic LY379268 (0, 0.3, and 3.0 mg/kg IP) on cue-induced reinstatement was tested in 3crit, (n ¼ 6) and 0crit (n ¼ 6) rats using a latin-square design with sessions repeated every third day (details in Supplementary Information).
Experiment 2: mGluR2 and mGluR3 Gene Expression Levels in Addict-like vs Non-Addict-like Rats. Rats were trained, characterized, and subjected to a cue-induced reinstatement session as described for experiment 1, except that rats did not receive LY379268 treatment. Subsequently, gene expression of mGluR2 and mGluR3 was investigated using quantitative in situ hybridization as described in Supplementary Information and previously (Hansson et al, 2003) .
Experiments in Mice
Male mGluR3 À / À and littermate control mice (Corti et al, 2007) were used in mouse self-administration experiments. Methods are fully described in Supplementary Information.
Experiment 3: Short-access cocaine self-administration, extinction, and cue-induced reinstatement of cocaineseeking in mGluR3 À / À and control mice.
Experiment 4: Long-access escalation of cocaine self-administration in mGluR3 À / À and control mice.
Data Analysis
Group scores for each addiction-like criterion (motivation for cocaine-taking, persistence of cocaine-seeking, resistance to punishment) and addiction score were analyzed by descriptive statistics (mean, standard error, and population distribution), but not by ANOVA, as being groups based on population extremes their differences are significant. For cue-induced reinstatement in rat and mice experiments, we used a combined within-(lever, time, dose) and betweensubject (group) ANOVA. In situ hybridization data were compared region-wise using one-way ANOVA. Overall analyses were followed by post hoc when appropriate. All data are expressed as mean values±SEM. Significance was set at po0.05.
For detailed statistical description, see Supplementary Information.
RESULTS
Experiment 1: Effect of LY379268 on Cue-Induced Reinstatement in Addict-like and Non-Addict-like Rats
Following cocaine self-administration training, rats were individually scored and assigned to groups based on the number of positive criteria met (0, 1, 2, and 3crit; Supplementary Figures S1-S4). Rats negative for all criteria (0crit) were characterized as non-addict-like, whereas rats positive for all criteria (3crit) were characterized as addictlike. The 3crit group scored higher in each addiction-like criterion than the 0crit group (Figure 1a-c), as well as for the addiction score, a computation of the three addictionlike criteria (Figure 1d ).
Following a 30-day withdrawal, we tested cue-induced reinstatement after either saline or LY379268 treatment in 0crit and 3crit rats (n ¼ 6/group). An analysis of patterns of nose-pokes during extinction under the control condition revealed that both groups enter the cue-reinstatement part of the session with a similar baseline and low responding on both of the holes (Supplementary Figure S5 ). An analysis of cue-induced reinstatement showed a significant effect between groups (F(1,10) ¼ 7.28; po0.05), indicating a different response between 0crit and 3crit, within holes (F(1,10) ¼ 18.85; po0.01), extinction/cue (F(1,10) ¼ 48.38; po0.0001), and holes Â extinction/cue interaction (F(1,10) ¼ 10.99; po0.01), indicating a discrimination between the two holes associated with the presentation of the cue. ANOVA also reported an overall effect of dose (F(2,20) ¼ 9.19; po0.01) and dose Â extinction/cue interaction (F(2,20) ¼ 10.90; po0.001), but no dose Â extinction/ cue Â groups interaction (F(2,20) ¼ 0.53; p40.05), indicating that LY379268 affected cue-induced reinstatement similarly in 0crit and 3crit rats. Post hoc analysis found no difference in extinction responding between 0crit and 3crit and within each group for any LY379268 dose, confirming that the two groups had a similar poke-baseline before exposure to the cue-reinstatement test, and that their baselines were not affected by LY379268 treatment (Figure 2a) . When discriminative and contingent cocainecues were presented, active nose-poking was reinstated in both groups (0crit po0.01, 3crit po0.001, vs extinction), and as expected was higher in 3crit rats compared with 0crit rats (po0.001). LY379268 reduced cue-induced reinstatement in both groups. In 0crit rats, both doses prevented reinstatement as no differences were observed within extinction and cue responding; in 3crit rats, the dose of 0.3 mg/kg reduced but did not block cue-induced reinstatement (po0.001 vs vehicle and extinction), whereas the dose of 3.0 mg/kg completely prevented cue-induced reinstatement, bringing the responses of 3crit rats to extinction level and values similar to 0crit (Figure 2a ). Inactive nose-poking was always low and at a similar level between 0crit and 3crit. The presentation of cocaine cues slightly increased inactive nose-poking in the 0crit group; however, this effect was not significant and was not a general feature of the group, due exclusively to a single subject (Figure 2a ). These results demonstrate that LY379268 blocked cumulative cue-induced reinstatement in both 0crit and 3crit rats, abolishing a critical addiction-like feature; ie, increased cue-induced reinstatement in subjects characterized as addict-like.
Next, we explored the effect of LY379268 on the time pattern of cue-induced reinstatement in the two groups. In line with the cumulative analysis above, ANOVA of the time pattern of nose-pokes resulted in a dose Â ext/cue Â time interaction (F(4,40) ¼ 3.31; po0.05) but no dose Â ext/cue Â time Â group interaction (F(4,40) ¼ 0.57; p40.05), indicating that LY379268 had a time-dependent effect on cue-induced reinstatement but this effect was similar between 0crit and 3crit; post hoc analysis confirmed that the two groups did not differ in pattern of responding during extinction and that dose effects of LY379268 were observable only during cue-induced reinstatement. However, browsing within post hoc data, we found a result worthy of mention, one hidden by the overall ANOVA; at the dose of 3.0 mg/kg, LY379268 decreased the number of nose-pokes in 0crit rats only during the first time bin of cue-induced reinstatement, an effect that disappeared in the second and third time bins; conversely, in the 3crit group, the anti-reinstatement effect of LY379268 lasted for the three cue-time bins (ie, with 3.0 mg/kg of LY379268 on board nose-poking was lower than control in each cue time bin). This result is unlikely to be a consequence of a higher number of nose-pokes produced by 3crit respect to 0crit under the control condition, as no significant differences were found in the second and third time bins between the groups (Figure 2b ). Thus, LY379268 seems to have a longer lasting anti-reinstatement effect in 3crit than in 0crit rats.
Experiment 2: mGluR2 and mGluR3 Gene Expression Levels in Addict-like vs Non-Addict-like Rats
As for experiment 1, we assigned each rat to one of the 0crit to 3crit groups based on the number of positive criteria met (Supplementary Figures S6-S9) , and we characterized 0crit (n ¼ 7) rats as non-addict-like and 3crit (n ¼ 5) as addictlike. Again, addict-like rats scored significantly higher than non-addict-like rats in each criterion as well as in the addiction score (Figure 3d ). Two 3crit and one 0crit rats died during baseline re-training after the addiction-like criteria tests or withdrawal, and could not be used for cue-induced reinstatement and in situ analysis, thus only three addict-like and six non-addict-like rats performed the cue-induced reinstatement test. ANOVA of cue-induced reinstatement showed, as expected, an overall effect between groups (F(1,7) ¼ 10.37; po0.05), within holes (F(1,7) ¼ 43.30; po0.001) and extinction/cue condition Figure 2 Experiment 1: The effect of mGluR2/3 agonist LY379268 on cue-induced reinstatement of cocaine-seeking was tested in rats characterized as addict-like (3crit, n ¼ 6) and non-addict-like (0crit n ¼ 6). (a) Effect of LY379268 on cumulative cue-induced reinstatement. Immediately after extinction, cue-induced reinstatement initiated, during which rats poked to activate the discrete cocaine cue. As expected, 3crit rats responded significantly more than 0crit. Both LY379268 doses prevented reinstatement of cocaine-seeking in 0crit rats. In the 3crit group, the highest dose abolished cue reinstatement while the lowest dose significantly decreased cocaine-seeking. (b) Time course of cue responding under control conditions and with the dose of 3.0 mg/kg during the three 10-min time bins of cue-induced reinstatement. Given the drop in responding observed from the first to the second time bin, for figure clarity the first 10-min time bin is scaled by the left y axis while the second and third are scaled by the right y axis. For further figure clarity, time bins of extinction and the dose of 0.3 mg/kg are omitted. Data are presented as mean±SEM; ***po0.001 vs 0crit same dose; ### po0.001 and #### po0.0001 vs extinction same dose; þ po0.05, þ þ po0.01, and þ þ þ þ po0.00001 vs vehicle treatment same group.
Anti-relapse effect of LY379268 in addict-like rats N Cannella et al (F(1,7) ¼ 64.17; po0.0001), and an overall interaction of the three factors (F(1,7) ¼ 12.89; po0.01); post hoc analysis confirmed no differences in active and inactive pokes and between groups during extinction. Presentation of cocaine-associated cues selectively reinstated active poking in both groups (0crit po0.05, 3crit po0.001, vs extinction), and active poking induced by cue presentation was significantly higher in 3crit as compared with 0crit rats (po0.01) (Figure 4a) .
After reinstatement testing, we examined mGluR2 and mGluR3 gene expression levels. The expression pattern of mGluR2 and mGluR3 was in agreement with previous findings (Ohishi et al, 1993; Tanabe et al, 1993) , and showed the highest expression levels for both genes in the cortex and dentate gyrus of the hippocampus (Supplementary Figure S10) . No significant differences in mGluR2 and mGluR3 expression were found between 0crit and 3crit rats in any investigated forebrain region. For F-and p-values, see Supplementary Table 1 , for mean ± SEM values in nCi/g, see Figure 4b .
Experiment 3: Cocaine Self-Administration, Extinction, and Cue-Induced Reinstatement in mGluR3 À / À and Control Mice
Before self-administration, lever training for food did not significantly differ between the two genotypes tested (data not shown). Acquisition of cocaine (0.75 mg/kg/infusion) self-administration measured over the first eight sessions also did not differ significantly between the two genotypes ( Figure 5a ). ANOVA on the number of infusions revealed no significant effect of genotype (F(1,16) ¼ 1.72; p40.05) or session Â genotype interaction (F(7,112) ¼ 0.65; p40.05). Similarly, no differences were found on the number of lever presses (Supplementary Figure S11A) . In a second phase, extinction and reinstatement of cocaine-seeking ( Figure 5b ) were measured following stable cocaine self-administration. Analysis of the number of lever presses for the last 3 days of cocaine self-administration followed by the extinction and reinstatement sessions revealed no significant effect of genotype (F(1,15) ¼ 1.34; p40.05) or session Â lever Â genotype interaction (F(16,240) ¼ 0.39; p40.05). These results demonstrate that removal of mGluR3 did not affect cue-induced reinstatement.
Experiment 4: Escalation of Cocaine Self-Administration in mGluR3 À / À and Control Mice During long access to cocaine self-administration (0.5 mg/kg/ infusion; 6-h daily sessions) without prior food training, mice from both genotypes rapidly self-administered an increasing amount of cocaine over sessions (Figure 5c ). Control and mGluR3 À / À mice displayed similar self-administration over the first 10 sessions (with a maximum of 100 infusions), as well as during the last session, when mice were able to self-administer up to 150 infusions. ANOVA on the number of cocaine infusions showed a significant effect of session (F(10,100) ¼ 19.1; po0.001) that indicates a session-dependent increase in drug-taking in mice from both genotypes. However, the effect of genotype and the genotype Â session interaction was not significant (F(1,10) ¼ 0.22; p40.05 and F(10,100) ¼ 0.8; p40.05, respectively). Lever presses showed a pattern similar to infusions (Supplementary Figure S11B) . These results indicate that the deletion of mGluR3 does not affect the 'escalation-like' pattern of self-administration seen in control mice when given long access to cocaine. Anti-relapse effect of LY379268 in addict-like rats N Cannella et al
DISCUSSION
The results reported here demonstrate that stimulation of mGluR2/3 is able to prevent excessive reinstatement of cocaine-seeking in addict-like rats. We replicated previous findings showing that an identical history of cocaine selfadministration yields at least two different, behavioral phenotypes, namely rats without addicted-like behavior (non-addict-like -0crit) and rats with addict-like behavior (3crit) (Deroche-Gamonet et al, 2004) . In comparison with 0crit, 3crit rats showed an exacerbated reinstatement of cocaine-seeking and pretreatment with LY379268 abolished cocaine-seeking in both groups. In a previous report by Kasanetz et al (2012) , decreased prefrontal expression of mGluR2/3 and impairment of mGluR2/3-mediated LTD were found in addict-like rats, supporting the hypothesis that addiction-like behavior is maintained by a downregulation of mGluR2/3 functions (see also Meinhardt et al, 2013) . In line with Kasanetz and co-worker, we found that the dose of LY379268 necessary to prevent reinstatement in addict-like rats is 10-fold higher than that necessary in nonaddict-like (Figure 2a) . In addition, an analysis of patterns of responses suggested that, though higher than in 0crit, in 3crit rats the effective dose of LY379268 has a longer lasting effect (Figure 2b) . To dissect the role of mGluR2 and mGluR3 in mediating cocaine addiction-like behavior, we examined gene expression patterns of both genes in brain sites known to be involved in mediating chronic drug effects (Koob et al, 2010; Noori et al, 2012) . After protracted abstinence (37-day withdrawal), no differences in mGluR2 and mGluR3 mRNA between 0crit and 3crit rats were found in any analyzed region. A decrease in mGluR2/3 proteins has been recently reported in the prefrontal cortex of cocaine-addict-like animals (Kasanetz et al, 2012) . Although Kazanetz and co-authors studied mGluR2/3 proteins at an earlier time point (24-h withdrawal), the lack of effects at the transcriptional level may indicate a translational regulation of mGluR2/3 in cocaine addiction. In a further attempt to dissect the role of these two receptors, we used knockout mice in the reinstatement and drug escalation model. Since mGluR2 À / À cannot be used in operant procedures due to motoric impairment (Morishima et al, 2005) , we only tested mGluR3 À / À . mGluR3 À / À mice did not show differences from controls in cocaine self-administration, cocaine escalation, extinction of cocaine-seeking, or cue-induced reinstatement. Together with our finding of unchanged mGluR3 expression in addict-like rats, our data suggest that mGluR2 function is critically involved as a negative feedback mechanism in regulating cue-induced reinstatement, and specific mGluR2 agonists or potentiators are candidate compounds for clinical testing. Currently, there are no selective agonists or antagonists available to pharmacologically dissect mGluR2 and mGluR3 function. Thus, our mice experiments represent a first step toward the dissection between mGluR2 and mGluR3 functions in reward processing. Earlier rat experiments using the same behavioral models that we used with mGluR3 À / À mice reported that LY379268 may block motivation for cocaine in escalated rats (Hao et al, 2010) and decreased cocaine self-administration and cue-induced reinstatement in short-access cocaine-experienced rats (Baptista et al, 2004; Lu et al, 2012) . Since LY379268 does not differentiate between mGluR2 and mGluR3, our mice experiments suggest a prominent role of mGluR2 in cocaine-seeking behavior. In line with this view, it has recently been demonstrated that the mGluR2-positive allosteric modulator BINA decreases cocaine self-administration, cue-induced reinstatement of cocaine-seeking, and the rewarding effects of cocaine, while being devoid of effects on food-driven behavior. In contrast, LY379268 had similar effects in cocaine and food-directed behavior (Jin et al, 2010) . Furthermore, several papers have reported that LY379268 treatment inhibits both drug and natural reward-seeking (Baptista et al, 2004; Lu et al, 2007; Peters and Kalivas, 2006; Uejima et al, 2007) . These studies suggest Anti-relapse effect of LY379268 in addict-like rats N Cannella et al that both mGluR2 and mGluR3 are involved in processing reward-directed behavior, while our data imply that mGluR2 has the primary critical role, at least with respect to cocaineseeking behavior. However, data collected until now suggest that to avoid unwanted side effects, cocaine addiction treatment targeting metabotropic group II glutamate receptors should utilize mGluR2-selective compounds.
The potential validity of mGluR2/3 as targets to treat relapse induced by drug conditioned stimuli may cover several addictive behaviors. In fact, beside cocaine, LY379268 was efficacious in blocking cue-and contextinduced reinstatement of alcohol, heroin, methamphetamine, nicotine, and natural reward-seeking (Bossert et al, 2004 (Bossert et al, , 2005 (Bossert et al, , 2006a Kufahl et al, 2011 Kufahl et al, , 2013 Liechti et al, 2007; Zhao et al, 2006) . This wide spectrum ranging from addictive to non-addictive rewards may suggest a more general role for mGluR2/3 in the conditioned effect of drugs. In support with this assumption, a recent paper demonstrated that the increase in dopamine concentration in the NAcs shell induced by a priming injection of nicotine could be blocked by LY379268 when the priming dose was injected in a nicotine-associated context, but not in a neutral context (D'Souza et al, 2011) . However, LY379268 can also reduce the primary reinforcing effect of ethanol (Sidhpura et al, 2010) , cocaine (Baptista et al, 2004) , and nicotine (Liechti et al, 2007) , and thus future studies should be addressed to differentiate the role of mGluR2/3 in conditioned and unconditioned effects of drugs.
Although LY379268 has previously been shown to be effective in dampening the reinstatement of cocaine-seeking induced by cues, stress, priming, and the incubation of cocaine-craving in rats (Baptista et al, 2004; Lu et al, 2007; Martin-Fardon and Weiss, 2012; Peters and Kalivas, 2006) , this is the first report showing its effectiveness in an animal model of cocaine addiction. Escalation of cocaine-seeking in rats has also been proposed to model some aspects of addiction (Ahmed and Koob, 1998; Lenoir et al, 2012) , and a previous report reported that LY379268 blunted motivation for cocaine more efficaciously (ie, at lower dose) in long-access cocaine-escalated rats than in short-access rats (Hao et al, 2010) . Furthermore, rats trained with a longaccess cocaine method showed a stable, elevated anxietylike behavior up to 42 days after discontinuation of cocainetaking that was higher than in short-access animals; importantly, long-access rats were more sensitive to the anxiolytic effect of LY379268 than short-access rats (Aujla et al, 2008) . These results are consistent with our report that 3.0 mg/kg of LY379268 seems to have a longer lasting effect in addict-like than in non-addict-like rats in a cuereinstatement session (Figure 2b ). However, in comparison with the cocaine escalation procedure, it is important to consider that the results presented here, as well as those in previous papers, demonstrated that a higher degree of drug exposure is not necessary ( Supplementary Figures S4 and  S9 ; Belin et al, 2008 Belin et al, , 2009 Deroche-Gamonet et al, 2004) or sufficient (Pelloux et al, 2007) to develop addiction-like behavior. In fact, it was reported that even after 72 days of cocaine self-administration, about 80% of long-access cocaine-escalated rats still do not differ from short-term access rats in compulsive behavior (Pelloux et al, 2007) . Therefore, testing the effects of LY379268 in addict-like and non-addict-like groups of rats may provide more suitable information for the direct translation into the clinical situation. However, we do not propose that the DSM-IVbased rat model of cocaine addiction used here can be routinely used for preclinical compound screening. The procedure is extremely time-consuming and labor-and cost-intensive. We propose that if other animal models, such as the reinstatement model of cocaine-seeking behavior, provide promising initial results with a novel putative anti-relapse compound, the use of the DSM-IVbased rat model would be advisable before clinical testing.
In conclusion, we have demonstrated that rats diagnosed with features of cocaine addiction are sensitive to the anti-relapse properties of LY379268, and we propose that the DSM-IV-based rat model of cocaine addiction is an important final step in the preclinical screening procedure of pharmacological candidates for addiction treatment. Figure 5 Experiment 3: mGluR3 À / À mice displayed normal cocaine self-administration, extinction, and reinstatement of cocaine-seeking. (a) Selfinfusions during the acquisition of cocaine self-administration (0.75 mg/kg/infusion) in mGluR3 À / À (n ¼ 7) and control (n ¼ 11) mice. (b) Extinction and reinstatement of cocaine-seeking following stable cocaine self-administration. Active (Act.) and inactive (Inact.) lever presses measured during the last 3 days of cocaine self-administration ( À 3 to À 1), 13 days of extinction (1-13) and the reinstatement test (R) in mGluR3 À / À and control mice. (c) Experiment 4: Long-access sessions of cocaine self-administration (0.5 mg/kg/infusion; 6-h daily sessions) in control (n ¼ 5) and mGluR3 À / À (n ¼ 7) mice. Graph shows the number of self-infusions during sessions 1-10 (with a maximum of 100 infusions), as well as during the last session, when mice were able to selfadminister up to 150 infusions.
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